Results 21 to 30 of about 10,516 (266)
Mean platelet volume in patients with prolactinoma [PDF]
Archives of Endocrinology and Metabolism, 2016 Objective Prolactin is a multifunctional pituitary hormone. The effect of prolactin on platelet activation is not well understood. Prolactinomas are the most common type of pituitary adenomas, and they are medically responsive to dopamine agonists. Mean
Abbas Ali Tam +4 more
doaj +3 more sources
Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea [PDF]
Endocrinology and Metabolism, 2021 Background Only a few studies have established the epidemiology of prolactinoma and Cushing’s disease in Korea. Furthermore, the incidence of these disease are increasing than before associated with the development of technologies.
Jin Sun Park +4 more
doaj +1 more source
Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients
Open Chemistry, 2019 The present investigation indicates hidden relationships between the several clinical parameters usually monitored on prolactinoma patients using non-hierarchical cluster analysis. The major goal of the chemometric data mining is to offer a possible mode
Nedyalkova Miroslava +3 more
doaj +2 more sources
Hyperprolactinemia and prolactinoma
, 2014 Prolactinomas are the most frequent pituitary adenomas. In patients with prolactinomas the primary cause of hyperprolactinemia is excessive and autonomic production of prolactin by lactotroph cells.
Johannes A. Romijn, Romijn, Johannes A.
core +4 more sources
Prolactinoma as a cause of persistent hyperprolactinemia in 6-Pyruvoyl-tetrahydropterin synthase deficiency [PDF]
, 2020 © 2020 The Authors. Published by Journal of Rare Diseases Research & Treatment. This is an open access article available under a Creative Commons licence.
Almadani, Ahmad +5 more
core +1 more source
Medicina, 2022 Prolactinomas are the commonest form of pituitary neuroendocrine tumor (PitNET), representing approximately half of such tumors. Dopamine agonists (DAs) have traditionally been the primary treatment for the majority of prolactinomas, with surgery considered the second line.
Inder, Warrick J., Jang, Christina
openaire +5 more sources
Arquivos Brasileiros de Endocrinologia & Metabologia, 2014 Os prolactinomas são os adenomas de hipófise mais comuns e frequentemente afetam mulheres jovens, em faixa etária de fertilidade. A hiperprolactinemia causa hipogonadismo, irregularidade menstrual ou amenorreia em mulheres, níveis baixos de testosterona sérica em homens e infertilidade e disfunção sexual em ambos os gêneros.
Glezer, Andrea, Bronstein, Marcello D.
openaire +4 more sources
Inhibiting MAPK14 showed anti-prolactinoma effect
BMC Endocrine Disorders, 2020 Background The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38α MAPK (MAPK14), p38β (MAPK11), p38γ (MAPK12) and p38δ (MAPK13 ...
Qiao-yan Ding +6 more
doaj +1 more source
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study
BMC Endocrine Disorders, 2021 Background Hyperprolactinaemia might cause adverse metabolic effects. The aim of our study was to compare parameters of body composition, glucose and lipid metabolism between untreated patients with prolactinoma and controls and to assess changes after ...
Anna Sophia Posawetz +7 more
doaj +1 more source
Interpretation of the 2022 ICCE/AME Position Statement for Clinical Practice in Pituitary Prolactinoma: Update on Clinical Characteristics and Points of Diagnosis and Treatment of Pituitary Prolactinoma [PDF]
Zhongguo quanke yixuePituitary prolactinoma is a neuroendocrine disease caused by excessive pituitary prolactin-cell adenoma synthesis and prolactin secretion. The standardized diagnosis and treatment of pituitary prolactinoma in of great significance for recovering and ...
TAN Huiwen, LI Danting, YU Yerong
doaj +1 more source